MKS (NASDAQ:MKSI) Price Target Raised to $215.00

MKS (NASDAQ:MKSI) had its price target hoisted by Bank of America from $200.00 to $215.00 in a report issued on Tuesday,Benzinga reports. They currently have a buy rating on the scientific and technical instruments company’s stock.

Several other equities analysts also recently weighed in on the stock. Benchmark lifted their target price on shares of MKS from $135.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, November 7th. Morgan Stanley reaffirmed an “overweight” rating and issued a $151.00 price objective on shares of MKS in a report on Monday, October 13th. Needham & Company LLC boosted their target price on shares of MKS from $136.00 to $170.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Wells Fargo & Company increased their target price on MKS from $135.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Friday, November 7th. Finally, Deutsche Bank Aktiengesellschaft set a $175.00 price target on MKS and gave the stock a “buy” rating in a report on Friday, October 31st. Nine research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $182.82.

MKS Stock Performance

NASDAQ:MKSI opened at $205.26 on Tuesday. The company has a market capitalization of $13.79 billion, a P/E ratio of 49.82, a P/E/G ratio of 1.75 and a beta of 1.92. The business has a fifty day simple moving average of $161.90 and a two-hundred day simple moving average of $131.61. The company has a debt-to-equity ratio of 1.64, a current ratio of 2.86 and a quick ratio of 1.81. MKS has a 1 year low of $54.84 and a 1 year high of $211.08.

MKS (NASDAQ:MKSI) last posted its quarterly earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.80 by $0.13. MKS had a return on equity of 20.80% and a net margin of 7.25%.The company had revenue of $988.00 million during the quarter, compared to the consensus estimate of $963.87 million. During the same quarter in the prior year, the company earned $1.72 EPS. The firm’s quarterly revenue was up 10.3% compared to the same quarter last year. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. On average, analysts expect that MKS will post 6.94 earnings per share for the current year.

MKS Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 24th were given a $0.22 dividend. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Monday, November 24th. MKS’s dividend payout ratio (DPR) is 21.36%.

Insider Buying and Selling

In related news, Director Elizabeth Mora sold 300 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $158.81, for a total transaction of $47,643.00. Following the completion of the transaction, the director directly owned 18,963 shares in the company, valued at $3,011,514.03. The trade was a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.57% of the stock is currently owned by insiders.

Institutional Trading of MKS

A number of large investors have recently modified their holdings of the business. Vanguard Group Inc. increased its position in shares of MKS by 4.0% in the third quarter. Vanguard Group Inc. now owns 7,752,097 shares of the scientific and technical instruments company’s stock worth $959,477,000 after purchasing an additional 295,480 shares during the last quarter. Cooke & Bieler LP grew its stake in MKS by 7.7% in the 3rd quarter. Cooke & Bieler LP now owns 1,321,877 shares of the scientific and technical instruments company’s stock worth $163,609,000 after buying an additional 94,692 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of MKS by 30.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,265,365 shares of the scientific and technical instruments company’s stock worth $156,602,000 after buying an additional 297,850 shares during the last quarter. Geode Capital Management LLC raised its position in shares of MKS by 2.9% during the 2nd quarter. Geode Capital Management LLC now owns 1,258,108 shares of the scientific and technical instruments company’s stock valued at $125,025,000 after buying an additional 35,065 shares in the last quarter. Finally, Channing Capital Management LLC lifted its holdings in shares of MKS by 79.3% during the 2nd quarter. Channing Capital Management LLC now owns 991,298 shares of the scientific and technical instruments company’s stock worth $98,495,000 after acquiring an additional 438,338 shares during the last quarter. Institutional investors own 99.79% of the company’s stock.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.